Polymer Capital Management (Us) LLC Uni Qure N.V. Transaction History
Polymer Capital Management (Us) LLC
- $945 Billion
- Q3 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 17,835 shares of QURE stock, worth $532,909. This represents 0.11% of its overall portfolio holdings.
Number of Shares
17,835Holding current value
$532,909% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding QURE
# of Institutions
269Shares Held
51.1MCall Options Held
3.94MPut Options Held
4.01M-
Avoro Capital Advisors LLC New York, NY4.44MShares$133 Million3.54% of portfolio
-
Rtw Investments, LP New York, NY4.42MShares$132 Million3.45% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$119 Million17.49% of portfolio
-
Abrdn PLC2.94MShares$87.8 Million0.28% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$59.4 Million0.03% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $1.4B
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...